Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GC-MRT vs Escitalopram in Social Anxiety Disorder
NCT03346239Completed
- Sponsor
- Tel Aviv University
- Start
- Jul 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of escitalopram in Social Anxiety Disorder (SAD), sponsored by Tel Aviv University. Primary endpoint: Liebowitz Social Anxiety Scale at 13 weeks. Started Jul 2018; status: completed.
02
Drugs
escitalopram
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT03346239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03346239.